Low Dose Thymoglobulin Result in Improved Outcomes after Allogeneic Unrelated Hematopoietic Stem Cell Transplantation (HCT) for Patients with Acute Myeloid Leukemia/Myelodysplastic Syndrome Conditioned with Intravenous Busulfan and Fludarabine
Meeting Abstract